BLOSSOMHILL THERAPEUTICS INC
BLSMNASDAQπ #2930 by market capUS Equity
$15.25βΌ $1.16 (β7.07%)
Pre-market Β· at closeTrack BLSM
Get earnings, price moves & breaking news on Telegram
24hβΌ 7.1%
7dβ² 4.9%
14dβ² 8.6%
30dβΌ 18.2%
ytdβ
1yβ
π¦Market Cap
$443M
Small Cap
πRevenue Growth (YoY)
0.0%
Slowing
πGross Margin
0.0%
Thin
π΅FCF Margin
0.0%
Thin
βοΈP/S Ratio
0.0x
Cheap
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $15.00 β $16.54
- 52-Week Range
- $12.93 β $27.99
- Volume (shares)
- 3,886
- Avg Volume (shares)
- β
- Shares Outstanding
- 29.1M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- -1.7
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-1.65
- Dividend Yield
- 0.00%
BLOSSOMHILL THERAPEUTICS INC
BLSMFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$64Mβ² +75.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$48Mβ² +52.3% YoY
About BLOSSOMHILL THERAPEUTICS INC
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst Ratings
βConsensus
Buy
11 analysts
Strong Buy4
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.